Mostrando 5 resultados de: 5
Filtros aplicados
Subtipo de publicación
Article(5)
Publisher
European Journal of Pharmaceutical Sciences(1)
International Journal of Molecular Sciences(1)
Nanomedicine: Nanotechnology, Biology, and Medicine(1)
Pharmaceutics(1)
Polymers(1)
Área temáticas
Farmacología y terapéutica(5)
Enfermedades(4)
Fisiología humana(1)
Fisiología y materias afines(1)
Ginecología, obstetricia, pediatría, geriatría(1)
Área de conocimiento
Farmacología(4)
Descubrimiento de fármacos(2)
Biomedicina(1)
Inflamación(1)
Medicamento(1)
Origen
scopus(5)
Comparative study of Ex Vivo transmucosal permeation of pioglitazone nanoparticles for the treatment of Alzheimer's disease
ArticleAbstract: Pioglitazone has been reported in the literature to have a substantial role in the improvement of ovPalabras claves:Alzheimer's disease, Nanoparticles, Pioglitazone, PLGA-PEG, Transmucosal permeationsAutores:Calpena A.C., Espina M., García M.L., Halbaut L., Lupe Carolina Espinoza, Silva-Abreu M.Fuentes:scopusNanoemulsion strategy of pioglitazone for the treatment of skin inflammatory diseases
ArticleAbstract: Pioglitazone (PGZ)is a peroxisome proliferator-activated receptor agonist. Its role in the inflammatPalabras claves:anti-inflammatory activity, cytokines, NANOEMULSIÓN, Pioglitazone, Skin disordersAutores:Calpena A.C., Clares-Naveros B., Fábrega M.J., Garduño-Ramírez M.L., Lupe Carolina Espinoza, Rodríguez-Lagunas M.J., Silva-Abreu M.Fuentes:scopusHuman skin permeation studies with PPARγ agonist to improve its permeability and efficacy in inflammatory processes
ArticleAbstract: Rosacea is the most common inflammatory skin disease. It is characterized by erythema, inflammatoryPalabras claves:inflammation, limonene, Pioglitazone, PPAR-γ, ROSÁCEA, Skin permeationAutores:Calpena A.C., Espina M., Fábrega M.J., García M.L., Lupe Carolina Espinoza, Rodríguez-Lagunas M.J., Silva-Abreu M.Fuentes:scopusThiazolidinedione as an alternative to facilitate oral administration in geriatric patients with Alzheimer's disease
ArticleAbstract: Pioglitazone (PGZ) is a member of the thiazolidinedione (TZDs) family of drugs and it is primarily uPalabras claves:Alzheimer's disease, Geriatric patients, Mucosal permeation, Oral administration, Pioglitazone, ThiazolidinedionesAutores:Calpena A.C., Espina M., García M.L., Gonzalez-Pizarro R., Lupe Carolina Espinoza, Rodríguez-Lagunas M.J., Silva-Abreu M.Fuentes:scopusTopical pioglitazone nanoformulation for the treatment of atopic dermatitis: Design, characterization and efficacy in hairless mouse model
ArticleAbstract: Pioglitazone (PGZ) is a drug used to treat type 2 diabetes mellitus that has been reported to show aPalabras claves:Atopic dermatitis, NANOEMULSIÓN, Pioglitazone, Pluronic F127Autores:Badia J., Calpena A.C., Clares-Naveros B., Domènech Ò., Lupe Carolina Espinoza, Rodríguez-Lagunas M.J., Silva-Abreu M., Vera-García R.Fuentes:scopus